GB9924992D0 - Pharmaceutical aerosol formulations - Google Patents

Pharmaceutical aerosol formulations

Info

Publication number: GB9924992D0
Authority: GB; United Kingdom
Prior art keywords: aerosol formulations; pharmaceutical aerosol; pharmaceutical; formulations; aerosol
Prior art date: 1999-10-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9924992.2A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-21

Filing date

1999-10-21

Publication date

1999-12-22

1999-10-21 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1999-10-21 Priority to GBGB9924992.2A priority Critical patent/GB9924992D0/en

1999-12-22 Publication of GB9924992D0 publication Critical patent/GB9924992D0/en

2000-10-19 Priority to AU13858/01A priority patent/AU1385801A/en

2000-10-19 Priority to AU11411/01A priority patent/AU1141101A/en

2000-10-19 Priority to PCT/EP2000/010305 priority patent/WO2001028514A1/en

2000-10-19 Priority to PCT/EP2000/010306 priority patent/WO2001028535A2/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

GBGB9924992.2A 1999-10-21 1999-10-21 Pharmaceutical aerosol formulations Ceased GB9924992D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GBGB9924992.2A GB9924992D0 (en)	1999-10-21	1999-10-21	Pharmaceutical aerosol formulations
AU13858/01A AU1385801A (en)	1999-10-21	2000-10-19	Pharmaceutical formulations
AU11411/01A AU1141101A (en)	1999-10-21	2000-10-19	Pharmaceutical aerosol formulations comprising s-salmeterol
PCT/EP2000/010305 WO2001028514A1 (en)	1999-10-21	2000-10-19	Pharmaceutical aerosol formulations comprising s-salmeterol
PCT/EP2000/010306 WO2001028535A2 (en)	1999-10-21	2000-10-19	Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9924992.2A GB9924992D0 (en)	1999-10-21	1999-10-21	Pharmaceutical aerosol formulations

Publications (1)

Publication Number	Publication Date
GB9924992D0 true GB9924992D0 (en)	1999-12-22

Family

ID=10863173

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9924992.2A Ceased GB9924992D0 (en)	1999-10-21	1999-10-21	Pharmaceutical aerosol formulations

Country Status (3)

Country	Link
AU (2)	AU1385801A (en)
GB (1)	GB9924992D0 (en)
WO (2)	WO2001028514A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR030516A1 (en) *	2000-08-31	2003-08-20	Glaxo Group Ltd	USE OF A COMBINATION OF SALMETEROL AND FLUTICASONA
GB0021927D0 (en) *	2000-09-07	2000-10-25	Glaxo Group Ltd	Use of pharmaceutical combination
GB0106031D0 (en) *	2001-03-12	2001-05-02	Glaxo Group Ltd	Use
GB0124523D0 (en) *	2001-10-12	2001-12-05	Glaxo Group Ltd	Pharmaceutical combination
EP1635844A1 (en) *	2003-05-22	2006-03-22	ALTANA Pharma AG	Salmeterol and ciclesonide combination
BRPI0613034A8 (en)	2005-07-14	2018-01-02	Lipothera Inc	injectable formulation for fat tissue accumulation, injectable formulation and method for treating fat accumulation, and method for reducing fat tissue.
US9132084B2 (en)	2009-05-27	2015-09-15	Neothetics, Inc.	Methods for administration and formulations for the treatment of regional adipose tissue
TR201000685A2 (en) *	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Pharmaceutical preparations containing salmeterol and fluticasone.
GEP201606551B (en)	2010-11-24	2016-10-10	Novamedica Llc	Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL104068A (en) *	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
EP1908488A3 (en) *	1995-04-14	2008-04-16	SmithKline Beecham Corporation	Metered dose inhaler for salmeterol
US6254882B1 (en) *	1997-09-16	2001-07-03	Sepracor Inc.	Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol

1999
- 1999-10-21 GB GBGB9924992.2A patent/GB9924992D0/en not_active Ceased
2000
- 2000-10-19 AU AU13858/01A patent/AU1385801A/en not_active Abandoned
- 2000-10-19 WO PCT/EP2000/010305 patent/WO2001028514A1/en not_active Ceased
- 2000-10-19 AU AU11411/01A patent/AU1141101A/en not_active Abandoned
- 2000-10-19 WO PCT/EP2000/010306 patent/WO2001028535A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU1141101A (en)	2001-04-30
WO2001028535A2 (en)	2001-04-26
AU1385801A (en)	2001-04-30
WO2001028535A3 (en)	2002-01-10
WO2001028514A1 (en)	2001-04-26

Publication	Publication Date	Title
IL139087A0 (en)	2001-11-25	Pharmaceutical aerosol formulation
IL147756A0 (en)	2002-08-14	Preserved pharmaceutical formulations
AU6310000A (en)	2001-03-05	Aerosol formulations
IL155088A0 (en)	2003-10-31	Medicinal aerosol formulations
AU6715600A (en)	2001-03-19	Pharmaceutical formulations
EP1173216A4 (en)	2004-09-29	Pharmaceutical formulations
GB9924992D0 (en)	1999-12-22	Pharmaceutical aerosol formulations
EP1221941A4 (en)	2005-11-30	Powder pharmaceutical formulations
GB9909154D0 (en)	1999-06-16	Pharmaceutical formulation
GB9906126D0 (en)	1999-05-12	Pharmaceutical formulations
GB9930578D0 (en)	2000-02-16	Pharmaceutical formulations
GB9926251D0 (en)	2000-01-12	Pharmaceutical formulation
GB0014849D0 (en)	2000-08-09	Pharmaceutical aerosol formulation
GB0014881D0 (en)	2000-08-09	Pharmaceutical aerosol formulation
GB9921289D0 (en)	1999-11-10	Pharmaceutical aerosol formulation
GB9905983D0 (en)	1999-05-12	Pharmaceutical formulations
GB9903177D0 (en)	1999-04-07	Pharmaceutical formulations
GB9911826D0 (en)	1999-07-21	Pharmaceutical formulations
GB9808152D0 (en)	1998-06-17	Pharmaceutical aerosol formulation
GB9814709D0 (en)	1998-09-02	Pharmaceutical aerosol formulation
SI1073417T1 (en)	2003-08-31	Pharmaceutical aerosol formulation
GB0024711D0 (en)	2000-11-22	Medicinal aerosol formulations
GB0128582D0 (en)	2002-01-23	Pharmaceutical aerosol formulations
GB9927685D0 (en)	2000-01-19	Pharmaceutical formulation
GB9921396D0 (en)	1999-11-10	Pharmaceutical formulation

Legal Events

Date	Code	Title	Description
2001-01-24	AT	Applications terminated before publication under section 16(1)